NEOVACS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1499 EUR | -12.13% |
|
-12.44% | -92.50% |
| 29/05 | Neovacs: mRNA approach validated in preclinical trial | CF |
| 27/05 | Neovacs: collaboration contract with INSERM team | CF |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 0.3700 | 0.5637 | 31.93 |
| Spread/Res. | -59.49% | -73.41% | -99.53% |
| Spread/Supp. | -11.77% | -11.77% | -11.77% |
| Support | 0.1699 | 0.1699 | 0.1699 |
- Stock Market
- Equities
- ALNEV Stock
- Charts NEOVACS
